Clinical Trial: A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.

U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152119) titled 'A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.' on Aug. 25.

Brief Summary: The purpose of this observation study is to learn about the safety and effects of the study medicine (called Litfulo) for the potential treatment of Severe Alopecia Areata.

Study Start Date: Sept. 01

Study Type: OBSERVATIONAL

Condition: Severe Alopecia Areata

Intervention: DRUG: Litfulo

as provided in real world practice.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Pfizer

Published by HT Digital Content Services with permission from Health Daily Digest....